Maxim raised the firm’s price target on Rezolute (RZLT) to $20 from $15 and keeps a Buy rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RZLT:
- Rezolute’s Promising Progress and Financial Strength Justify Buy Rating
- Rezolute’s Promising Outlook: Buy Rating Affirmed Amid Strategic Advancements and Strong Clinical Progress
- Rezolute, Inc. Reports Fiscal 2025 Financial Results
- Rezolute reports Q4 EPS (26c), consensus (23c)
- Rezolute, Inc. (RZLT) Q4 Earnings Cheat Sheet